Average Co-Inventor Count = 11.39
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (26 from 1,979 patents)
26 patents:
1. 12509442 - KIF18A inhibitors
2. 12473289 - Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
3. 12459932 - KIF18A inhibitors
4. 12440491 - KRAS G12C inhibitors and methods of using the same
5. 12083121 - Substituted piperazines as KRAS G12C inhibitors
6. 12054476 - KIF18A inhibitors
7. 11766436 - KRAS G12C inhibitors and methods of using the same
8. 11285156 - Substituted piperazines as KRAS G12C inhibitors
9. 11279712 - Macrocyclic compounds that inhibit MCL-1 protein
10. 11090304 - KRAS G12C inhibitors and methods of using the same
11. 11053226 - KRAS G12C inhibitors and methods of using the same
12. 10889581 - Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
13. 9611261 - Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
14. 9550762 - Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
15. 9096527 - TRPM8 antagonists and their use in treatments